1. Home/
  2. Compounds/
  3. BRD-A02303741:navitoclax (2:1 mol/mol)

BRD-A02303741:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2BRD-A02303741:navitoclax (2:1 mol/mol)
PharmacoGx BRD-A02303741:navitoclax (2:1 mol/mol)

Cell lines tested with BRD-A02303741:navitoclax (2:1 mol/mol)

782 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with BRD-A02303741:navitoclax (2:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2140
lungCTRPv2138
skinCTRPv245
large intestineCTRPv244
central nervous systemCTRPv242
ovaryCTRPv241
pancreasCTRPv240
N/ACTRPv238
breastCTRPv232
stomachCTRPv229
Download CSV
Download Data as CSV

Top molecular features associated with response to BRD-A02303741:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FIS1 CTRPv2 AAC -6.8e-05 1
mRNA PPT2 CTRPv2 AAC -6.1e-05 1
mRNA SERP1 CTRPv2 AAC 5.1e-05 1
mRNA TNMD CTRPv2 AAC 3.3e-05 1
mRNA PLG CTRPv2 AAC 3e-05 1
mRNA ZSWIM7 CTRPv2 AAC 3e-05 1
mRNA FGFBP2 CTRPv2 AAC 2.9e-05 1
mRNA ANTXR2 CTRPv2 AAC -2.6e-05 1
mRNA FGFBP3 CTRPv2 AAC -1.7e-05 1
mRNA PDZD3 CTRPv2 AAC -1.5e-05 1
Download CSV